Bo Li

10PUBLICATIONS
89CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markersInnate immunityMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 05, 2026
The Hippo Pathway Is Dysregulated in Cancer-Associated Fibroblasts in Anti-PD-L1-Resistant Cancer.

Juliette Roels, Hamid Ghaedi, Jayaram Kancherla

|Feb 26, 2025
Author Correction: Multiplexed, image-based pooled screens in primary cells and tissues with PerturbView.

Takamasa Kudo, Ana M Meireles, Reuben Moncada

|Oct 07, 2024
Multiplexed, image-based pooled screens in primary cells and tissues with PerturbView.

Takamasa Kudo, Ana M Meireles, Reuben Moncada

|Oct 19, 2021
Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer.

Tamara Ouspenskaia, Travis Law, Karl R Clauser

|Apr 29, 2021
COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets.

Toni M Delorey, Carly G K Ziegler, Graham Heimberg

|Nov 03, 2020
Author Correction: Nuclei multiplexing with barcoded antibodies for single-nucleus genomics.

Jellert T Gaublomme, Bo Li, Cristin McCabe

Pageof 2

Frequent Collaborators

6 joint publications

Yiming Yang

6 joint publications

Aviv Regev

3 joint publications

Nir Hacohen

2 joint publications

Danielle Dionne